October 16, 2018 Clinical Research/Diagn. Lab Top-10 Life Science Tools M&A, Partnerships

Thermo Fisher Scientific Custom Microarrays Drive Large-Scale Genotyping Study of Finnish Population

Thermo Fisher Scientific Custom Microarrays Drive Large-Scale Genotyping Study of Finnish Population FinnGen, a first-of-its-kind study of 500,000 individuals, combines genomics and health record data to better understand disease origins and improve human health SANTA CLARA, Calif., Oct. 16, 2018 /PRNewswire/ — Thermo Fisher Scientific today announced facilitation of the next phase of the FinnGen precision... Read more

October 16, 2018 Clinical Research/Diagn. Lab Top-10 Liq. Handling & Robotics M&A, Partnerships

Bruker Completes Acquisition of Majority Interest in Infectious Disease Molecular Diagnostics Company Hain Lifescience GmbH

– Acquisition expands Bruker’s Microbiology & Diagnostics business with profitable Molecular Diagnostics portfolio and substantial innovation pipeline – Novel Fluorocycler™ XT thermal cycler with high multiplexing real-time PCR capabilities enables proprietary, new Liquid Array™ assay format for affordable syndromic panels – Expanded FluoroType™ MTBDR 2.0 Liquid Array assay provides highly differentiated tuberculosis (TB) detection and... Read more

October 16, 2018 Clinical Research/Diagn. Liq. Handling & Robotics M&A, Partnerships

Bruker Completes Acquisition of Majority Interest in Infectious Disease Molecular Diagnostics Company Hain Lifescience GmbH

BILLERICA, Mass., Oct. 16, 2018 /PRNewswire/ — Bruker Corporation (NASDAQ: BRKR) today announced that is has completed the acquisition of an 80% majority interest in Hain Lifescience GmbH, based in Nehren, Germany.  Hain is an infectious disease specialist with a broad range of molecular diagnostics (MDx) solutions for the detection of microbial and viral pathogens, as... Read more

October 15, 2018 Clinical Research/Diagn. M&A, Partnerships

Roche Diagnostics partners with DASA Group to create the world’s largest integrated core lab* today

Partnership that grows stronger While DASA has experienced unprecedented growth and success with their integrated lab, they don’t plan on slowing down. Alessandro Veiga states, “We haven’t stopped growing. DASA has an expectation to become a global leader in diagnostic medicine throughout the world.” DASA Group’s vision is to be the best company in the... Read more

October 15, 2018 Clinical Research/Diagn. Life Science Tools PR/Corporate

NanoString Announces $100 Million Term Loan Facility with CRG

October 15, 2018 09:00 ET | Source: NanoString Technologies, Inc. SEATTLE, Oct. 15, 2018 (GLOBE NEWSWIRE) — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it has entered into a new $100 million term loan facility with the CR Group L.P. (CRG), a health care focused... Read more

October 15, 2018 Clinical Research/Diagn. Informatics & Software M&A, Partnerships

Microsoft Genomics ventures into the microbiome with Eagle Genomics

October 15, 2018 Cambridge technology innovators partner with Microsoft Genomics Microbiomic research into immune disorders and antibiotic resistance First microbiome partnership for Microsoft LONDON — October 2018 — The data scientists and developers behind a ground-breaking microbiome data platform, today, announced their partnership with Microsoft Genomics, a Microsoft Azure service dedicated to meeting the computational... Read more

October 15, 2018 Clinical Research/Diagn. Life Science Tools Product Launch

Roche launches NGS AVENIO Tumor Tissue Analysis Kits for oncology research

Basel, 15 October 2018 Roche launches NGS AVENIO Tumor Tissue Analysis Kits for oncology research Ready-to-use kits determine genomic characteristics of solid tumours Optimized workflow to generate results in house Software analysis allows correlation to AVENIO ctDNA NGS kits Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the global commercial launch of three new next-generation... Read more

October 12, 2018 Clinical Research/Diagn.

SYNTAX III Study Identifies CT as Non-Invasive Alternative to Help Heart Teams Guide Treatment for Complex Coronary Disease

Waukesha, WI  – October 12, 2018– A new study published in the European Heart Journal shows computed tomography (CT) can be a useful aid in heart team decision making for complex coronary disease. Results also suggest the state-of-the-art imaging technology may offer a non-invasive diagnostic alternative to conventional coronary angiography. Coronary artery disease (CAD) and... Read more

October 12, 2018 Clinical Research/Diagn. M&A, Partnerships

Bio-Techne Signs Strategic Cooperation Agreement with Micropoint Bioscience

OCTOBER 12, 2018 MINNEAPOLIS, Oct. 12, 2018 /PRNewswire/ — Bio-Techne has entered into a strategic cooperation agreement with Micropoint Bioscience of Shenzhen, China. Chuck Kummeth, President and CEO of Bio-Techne, Yan Pingyi, Chairman of Micropoint Bioscience, and Wang Bin, Executive Vice President, Shenzhen Association of Medical Devices, all attended the meeting and signing ceremony. Micropoint... Read more

October 11, 2018 Clinical Research/Diagn. Life Science Tools Product Launch

Paragon Genomics Introduces CleanPlex® UMI Panel for Ultrafast, Precise Analysis of Lung Cancer Hotspot Mutations at ASHG 2018

–First Product in Family of New CleanPlex® UMI NGS Panels that Deliver Highly Accurate Results in Detecting Low-Frequency Variants and Mutations for Liquid Biopsy and Other Applications –ASHG Poster Shows CleanPlex Unique Molecular Identifier (UMI) Technology Enables Allele Frequency Detection Down to 0.1% in Fast, Simple-to-Construct Libraries –Paragon Genomics’ Education Event at ASHG Will Describe How... Read more